Please use this identifier to cite or link to this item:
Title: Comprehensive long-term efficacy and safety of recombinant human alpha-mannosidase (velmanase alfa) treatment in patients with alpha-mannosidosis.
Issue Date: Nov-2018
Citation: J. Inherit. Metab. Dis..2018 Nov;(41)6:1225-1233
Abstract: Long-term outcome data provide important insights into the clinical utility of enzyme replacement therapies. Such data are presented for velmanase alfa in the treatment of alpha-mannosidosis (AM).
PMID: 29725868
Rights: openAccess
Appears in Collections:Hospitales > H. Central de la Cruz Roja San José y Santa Adela > Artículos

Files in This Item:
File Description SizeFormat 
PMC6326957.pdf499.99 kBAdobe PDFThumbnail

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.